Inhibiting mtDNA-STING-NLRP3/IL-1β axis-mediated neutrophil infiltration protects neurons in Alzheimer's disease

Xiangyu Xia, Xuemei He, Tingmei Zhao, Jingyun Yang, Zhenfei Bi, Qianmei Fu, Jian Liu, Danyi Ao, Yuquan Wei, Xiawei Wei

PDF
Cell Proliferation ›› 2024, Vol. 57 ›› Issue (1) : e13529. DOI: 10.1111/cpr.13529
ORIGINAL ARTICLE

Inhibiting mtDNA-STING-NLRP3/IL-1β axis-mediated neutrophil infiltration protects neurons in Alzheimer's disease

Author information +
History +

Abstract

Neutrophil is a pathophysiological character in Alzheimer's disease. The pathogen for neutrophil activation in cerebral tissue is the accumulated amyloid protein. In our present study, neutrophils infiltrate into the cerebra in two models (transgenic model APP/PS1 and stereotactic injection model) and promote neuron apoptosis, releasing their cellular constituents, including mitochondria and mitochondrial DNA (mtDNA). We found that both Aβ1–42 and mtDNA could provoke neutrophil infiltration into the cerebra, and they had synergistic effects when they presented together. This neutrophillic neuroinflammation upregulates expressions of STING, NLRP3 and IL-1β. These inflammatory cytokines with mtDNA constitute the mtDNA-STING-NLRP3/IL-1β axis, which is the prerequisite for neutrophil infiltration. When any factor in this pathway is depleted, the migration of neutrophils into cerebral tissue is ceased, with neurons and cognitive function being protected. Thus, we provide a novel perspective to alleviate the progression of Alzheimer's disease.

Cite this article

Download citation ▾
Xiangyu Xia, Xuemei He, Tingmei Zhao, Jingyun Yang, Zhenfei Bi, Qianmei Fu, Jian Liu, Danyi Ao, Yuquan Wei, Xiawei Wei. Inhibiting mtDNA-STING-NLRP3/IL-1β axis-mediated neutrophil infiltration protects neurons in Alzheimer's disease. Cell Proliferation, 2024, 57(1): e13529 https://doi.org/10.1111/cpr.13529

References

[1]
Alzheimer A. About a peculiar disease of the cerebral cortex. By Alois Alzheimer, 1907 (translated by L. Jarvik and H. Greenson). Alzheimer Dis Assoc Disord. 1987;1(1):3-8.
[2]
Knopman DS, Amieva H, Petersen RC, et al. Alzheimer disease. Nat Rev Dis Primers. 2021;7:1.
[3]
Masters CL, Bateman R, Blennow K, et al. Alzheimer's disease. Nat Rev Dis Primers. 2015;1(1):1-18.
[4]
Godyń J, Jończyk J, Panek D, Malawska B. Therapeutic strategies for Alzheimer's disease in clinical trials. Pharmacol Rep. 2016;68(1):127-138.
[5]
Heppner FL, Ransohoff RM, Becher B. Immune attack: the role of inflammation in Alzheimer disease. Nat Rev Neurosci. 2015;16(6):358-372.
[6]
Um JW, Nygaard HB, Heiss JK, et al. Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons. Nat Neurosci. 2012;15(9):1227-1235.
[7]
Rönicke R, Mikhaylova M, Rönicke S, et al. Early neuronal dysfunction by amyloid β oligomers depends on activation of NR2B-containing NMDA receptors. Neurobiol Aging. 2011;32(12):2219-2228.
[8]
Wyss-Coray T. Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat Med. 2006;12(9):1005-1015.
[9]
Gu L, Guo Z. Alzheimer's Aβ42 and Aβ40 form mixed oligomers with direct molecular interactions. Biochem Biophys Res Commun. 2020;534:292-296.
[10]
Golde TE, Petrucelli L, Lewis J. Targeting Aβ and tau in Alzheimer's disease, an early interim report. Exp Neurol. 2010;223(2):252-266.
[11]
Crouch PJ, Harding SME, White AR, Camakaris J, Bush AI, Masters CL. Mechanisms of Aβ mediated neurodegeneration in Alzheimer's disease. Int J Biochem Cell Biol. 2008;40(2):181-198.
[12]
Cieślik M, Czapski GA, Strosznajder JB. The molecular mechanism of amyloid β42 peptide toxicity: the role of sphingosine Kinase-1 and mitochondrial sirtuins. PloS One. 2015;10(9):e0137193.
[13]
Tsatsanis A, Wong BX, Gunn AP, et al. Amyloidogenic processing of Alzheimer's disease β-amyloid precursor protein induces cellular iron retention. Mol Psychiatry. 2020;25(9):1958-1966.
[14]
Li X, Lei P, Tuo Q, et al. Enduring elevations of hippocampal amyloid precursor protein and iron are features of beta-amyloid toxicity and are mediated by tau. Neurotherapeutics. 2015;12(4):862-873.
[15]
Lecanemab confirmatory phase 3 clarity ad study met primary endpoint, showing highly statistically significant reduction of clinical decline in large global clinical study of 1,795 participants with early Alzheimer's disease. https://www.eisai.com/index.html. September 28, 2022
[16]
Daniels MJD, Rivers-Auty J, Schilling T, et al. Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer's disease in rodent models. Nature Communications. 2016;7:12504.
[17]
Heneka MT, Kummer MP, Stutz A, et al. NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice. Nature. 2013;493(7434):674-678.
[18]
Berg JV, Prokop S, Miller KR, et al. Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease-like pathology and cognitive decline. Nat Med. 2012;18(12):1812-1819.
[19]
Jekabsone A, Mander PK, Tickler A, Sharpe M, Brown GC. Fibrillar beta-amyloid peptide Aβ1–40 activates microglial proliferation via stimulating TNF-α release and H2O2 derived from NADPH oxidase: a cell culture study. J Neuroinflammation. 2006;3(1):24.
[20]
Mu T, Guan Y, Chen T, et al. Black raspberry anthocyanins protect BV2 microglia from LPS-induced inflammation through down-regulating NOX2/TXNIP/NLRP3 signaling. J Berry Res. 2021;10:1-15.
[21]
Khoury JE, Hickman SE, Thomas CA, Cao L, Silverstein SC, Loike JD. Scavenger receptor-mediated adhesion of microglia to |[beta]|-amyloid fibrils. Nature. 1996;382(6593):716-719.
[22]
Zenaro E, Pietronigro E, Bianca VD, et al. Neutrophils promote Alzheimer's disease-like pathology and cognitive decline via LFA-1 integrin. Nat Med. 2015;21:880-886.
[23]
Baik SH, Cha MY, Hyun YM, et al. Migration of neutrophils targeting amyloid plaques in Alzheimer's disease mouse model. Neurobiol Aging. 2014;35(6):1286-1292.
[24]
Stock AJ, Anne KJ, Anne PH. The role of neutrophil granule proteins in neuroinflammation and Alzheimer's disease. J Neuroinflammation. 2018;15(1):240.
[25]
Wu CY, Bawa KK, Ouk M, et al. Neutrophil activation in Alzheimer's disease and mild cognitive impairment: a systematic review and meta-analysis of protein markers in blood and cerebrospinal fluid. Ageing Res Rev. 2020;62:101130.
[26]
Wei X, Shao B, He Z, et al. Cationic nanocarriers induce cell necrosis through impairment of Na(+)/K(+)-ATPase and cause subsequent inflammatory response. Cell Res. 2015;25(2):237-253.
[27]
Qian Y, Liang X, Yang J, et al. Hyaluronan reduces cationic liposome-induced toxicity and enhances the antitumor effect of targeted gene delivery in mice. ACS Appl Mater Interfaces. 2018;10(38):32006-32016.
[28]
Yang SJ, Han AR, Kim EA, et al. KHG21834 attenuates glutamate-induced mitochondrial damage, apoptosis, and NLRP3 inflammasome activation in SH-SY5Y human neuroblastoma cells. Eur J Pharmacol. 2019;856:172412.
[29]
Oka T, Hikoso S, Yamaguchi O. Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure. Nature. 2012;485(7397):251-255.
[30]
Zhong Z, Liang S, Sanchez-Lopez E, et al. New mitochondrial DNA synthesis enables NLRP3 inflammasome activation. Nature. 2018;560(7717):198-203.
[31]
Tian Y, Bao Z, Ji Y, Mei X, Yang H. Epigallocatechin-3-gallate protects H2O2-induced nucleus pulposus cell apoptosis and inflammation by inhibiting cGAS/Sting/NLRP3 activation. Drug Des Devel Ther. 2020;14:2113-2122.
[32]
Wang W, Hu D, Feng Y, et al. STING Recruits NLRP3 to the ER and Deubiquitinates NLRP3 to Activate the Inflammasome. Cold Spring Harbor Laboratory; 2019.
[33]
Justin BC, Scott AS, Douglas GW, et al. Source and purity of dengue-viral preparations impact requirement for enhancing antibody to induce elevated IL-1β secretion: A primary human monocyte model. PLoS One. 2015;10(8):e0136708.
[34]
Fang XX, Sun GL, Zhou Y, et al. TGF-β1 protection against Aβ_(1-42)-induced neuroinflammation and neuronal apoptosis in rat hippocampus. NeuroReport. 2015;29(2):141-146.
[35]
Szczepanik AM, Ringheim GE. IL-10 and glucocorticoids inhibit Aβ(1–42)- and lipopolysaccharide-induced pro-inflammatory cytokine and chemokine induction in the central nervous system. J Alzheimers Dis. 2003;5(2):105-117.
[36]
Shen WX, Chen JH, Lu JH, Peng YP, Qiu YH. TGF-β1 protection against Aβ1–42-induced neuroinflammation and neurodegeneration in rats. Int J Mol Sci. 2014;15(12):22092-22108.
[37]
Dokumacı AH, Aycan MBY. Vildagliptine protects SH-SY5Y human neuron-like cells from Aβ 1-42 induced toxicity, in vitro. Cytotechnology. 2019;71(2):635-646.
[38]
Crouch PJ, Barnham KJ, Duce JA, Blake RE, Masters CL, Trounce IA. Copper-dependent inhibition of cytochrome c oxidase by Abeta(1-42) requires reduced methionine at residue 35 of the Abeta peptide. J Neurochem. 2010;99(1):226-236.
[39]
Sotthibundhu A, Sykes AM, Fox B, et al. Beta-amyloid(1-42) induces neuronal death through the p75 neurotrophin receptor. J Neurosci. 2008;28(15):3941-3946.
[40]
Yang Y, Wang M, Lv B, et al. Sphingosine Kinase-1 protects differentiated N2a cells against beta-amyloid25–35-induced neurotoxicity via the mitochondrial pathway. Neurochem Res. 2014;39(5):932-940.
[41]
McManus MJ, Murphy MP, Franklin JL. Mitochondria-derived reactive oxygen species mediate caspase-dependent and -independent neuronal deaths. Mol Cell Neurosci. 2014;63:13-23.
[42]
Rojas-Charry L, Calero-Martinez S, Morganti C, et al. Susceptibility to cellular stress in PS1 mutant N2a cells is associated with mitochondrial defects and altered calcium homeostasis. Sci Rep. 2020;10(1):6455.
[43]
Tanaka Y, Chen ZJ. STING specifies IRF3 phosphorylation by TBK1 in the cytosolic DNA signaling pathway. Sci Signal. 2012;5(214):ra20.
[44]
Zhou Q, Lin H, Wang S, et al. The ER-associated protein ZDHHC1 is a positive regulator of DNA virus-triggered, MITA/STING-dependent innate immune signaling. Cell Host Microbe. 2014;16(4):450-461.
[45]
Nandakumar R, Tschismarov R, Meissner F, et al. Intracellular bacteria engage a STING–TBK1–MVB12b pathway to enable paracrine cGAS–STING signalling. Nature Microbiology. 2019;4:701-713.
[46]
Li W, Lu L, Lu J, et al. cGAS-STING-mediated DNA sensing maintains CD8+ T cell stemness and promotes antitumor T cell therapy. Sci Transl Med. 2020;12(549):eaay9013.
[47]
Wu Y, Wei Q, Yu J. The cGAS/STING pathway: a sensor of senescence-associated DNA damage and trigger of inflammation in early age-related macular degeneration. Clin Interv Aging. 2019;14:1277-1283.
[48]
White MJ, McArthur K, Metcalf D, et al. Apoptotic caspases suppress mtDNA-induced STING-mediated type I IFN production. Cell. 2014;159(7):1549-1562.
[49]
Andreeva L, Wu H. STING condensates on ER limit IFN response. Nat Cell Biol. 2021;23(4):299-300.
[50]
Dong X, Zheng Z, Lin P, et al. ACPAs promote IL-1β production in rheumatoid arthritis by activating the NLRP3 inflammasome. Cell Mol Immunol. 2019;17(3):261-271.
[51]
Turley JL, Moran HBT, McEntee CP, et al. Chitin-derived polymer deacetylation regulates mitochondrial reactive oxygen species dependent cGAS-STING and NLRP3 inflammasome activation. Biomaterials. 2021;275(2):120961.
[52]
Tan M-S, Yu J-T, Jiang T, et al. The NLRP3 inflammasome in Alzheimer's disease. Mol Neurobiol. 2013;48(3):875-882.
[53]
Paul BD, Snyder SH, Bohr VA. Signaling by cGAS–STING in neurodegeneration, neuroinflammation, and aging. Trends Neurosci. 2020;44(2):83-96.
[54]
Perry RT, Collins JS, Wiener H, et al. The role of TNF and its receptors in Alzheimer's disease. Neurobiol Aging. 2001;22(6):873-883.
[55]
Chen R, Yin Y, Zhao Z, et al. Elevation of serum TNF-α levels in mild and moderate Alzheimer patients with daytime sleepiness. J Neuroimmunol. 2012;244(1–2):97-102.

RIGHTS & PERMISSIONS

2023 2023 The Authors. Cell Proliferation published by Beijing Institute for Stem Cell and Regenerative Medicine and John Wiley & Sons Ltd.
PDF

Accesses

Citations

Detail

Sections
Recommended

/